Target intelligence / Profile preview

DSTN pseudogene 4 (DSTNP4)

Target
DSTNP4
Molecular classification
Pseudogene, Other
01

Overview

DSTN pseudogene 4 (DSTNP4) is a noncoding genomic DNA sequence that closely resembles the coding gene DSTN (Destrin) but has accumulated mutations preventing it from encoding a functional protein[3][5][7]. As a pseudogene, DSTNP4 is not typically transcribed or translated into a functional protein. Current scientific evidence indicates that most pseudogenes, including DSTNP4, do not act as traditional therapeutic targets such as receptors, enzymes, or transporters[3][5][7]. While select pseudogenes can participate in gene regulation at the RNA level—such as acting as miRNA sponges or generating antisense transcripts—there is no evidence in the literature that DSTNP4 specifically serves any regulatory function, is a biomarker, or interacts with drugs[1][3][5]. Broadly, the study of pseudogenes like DSTNP4 has highlighted roles in genomic evolution and, for some pseudogenes, possible contributions to disease if their transcripts regulate parental gene expression or act as competing endogenous RNAs[1][4][6]. However, such functions have not been reported for DSTNP4 specifically. In summary: DSTN pseudogene 4 is a bona fide human pseudogene with no protein product, no known therapeutic role, no disease association, and no direct relevance as a drug target[3][5][7].

Other names
DSTN pseudogene 4DSTNP4
02

Biological functions

Potential RNA-level regulation (e.g., miRNA sponging, antisense RNA generation)Other
03

Disease associations

Other (some pseudogenes are implicated in cancer and gene regulation, though no disease association for DSTNP4 specifically is established)

Beyond the preview

Go deeper on DSTN pseudogene 4 (DSTNP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DSTN pseudogene 4 (DSTNP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call